Works matching IS 00071048 AND DT 2018 AND VI 181 AND IP 4
Results: 23
PDCD1LG2 (PD-L2) RNA in situ hybridization is a sensitive, specific, and practical marker of primary mediastinal large B-cell lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 564, doi. 10.1111/bjh.14670
- By:
- Publication type:
- Article
Investigational agents in immunotherapy: a new horizon for the treatment of multiple myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 433, doi. 10.1111/bjh.15116
- By:
- Publication type:
- Article
Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 539, doi. 10.1111/bjh.14634
- By:
- Publication type:
- Article
Age matters in ALL.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 429, doi. 10.1111/bjh.15205
- By:
- Publication type:
- Article
Novel chemotherapy-free combination regimen for ibrutinib-resistant mantle cell lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 561, doi. 10.1111/bjh.14669
- By:
- Publication type:
- Article
Immunophenotypic analysis of cell cycle status in acute myeloid leukaemia: relationship to cytogenetics, genotype and clinical outcome.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 486, doi. 10.1111/bjh.15211
- By:
- Publication type:
- Article
Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 515, doi. 10.1111/bjh.15208
- By:
- Publication type:
- Article
Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease A British Society for Haematology Guideline.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 460, doi. 10.1111/bjh.15235
- By:
- Publication type:
- Article
Increased lymphocyte cell size with blastoid morphology associated with splenic rupture following cessation of ibrutinib.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Time to treatment is an independent prognostic factor in aggressive non-Hodgkin lymphomas.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 495, doi. 10.1111/bjh.15224
- By:
- Publication type:
- Article
Factor (F)VIII/VIIa enhances global haemostatic function in the co-presence of bypassing agents and FVIII among patients with haemophilia A with inhibitor.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 528, doi. 10.1111/bjh.15209
- By:
- Publication type:
- Article
Wilms Tumor 1 gene expression levels improve risk stratification in AML patients. Results of a multicentre study within the Spanish Group for Molecular Biology in Haematology.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 542, doi. 10.1111/bjh.14635
- By:
- Publication type:
- Article
An effective modestly intensive re-induction regimen with bortezomib in relapsed or refractory paediatric acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 523, doi. 10.1111/bjh.15233
- By:
- Publication type:
- Article
Risk factors for Burkitt lymphoma: a nested case-control study in the UK Clinical Practice Research Datalink.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 505, doi. 10.1111/bjh.15229
- By:
- Publication type:
- Article
A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 476, doi. 10.1111/bjh.15207
- By:
- Publication type:
- Article
Quality assurance and tests of platelet function.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 560, doi. 10.1111/bjh.14668
- By:
- Publication type:
- Article
Multinucleated giant myeloma cells after failure of daratumumab therapy.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Results of a multicentre UK-wide compassionate use programme evaluating the efficacy of idelalisib monotherapy in relapsed, refractory follicular lymphoma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 555, doi. 10.1111/bjh.14665
- By:
- Publication type:
- Article
Current use of monoclonal antibodies in the treatment of multiple myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 447, doi. 10.1111/bjh.15121
- By:
- Publication type:
- Article
Haem augments and iron chelation decreases toll-like receptor 4 mediated inflammation in monocytes from sickle cell patients.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 552, doi. 10.1111/bjh.14663
- By:
- Publication type:
- Article
Heavy/light chain ratio for the assessment of minimal residual disease in myeloma patients achieving complete response.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 550, doi. 10.1111/bjh.14662
- By:
- Publication type:
- Article
Clonal haematopoiesis is not prevalent in survivors of childhood cancer.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 537, doi. 10.1111/bjh.14630
- By:
- Publication type:
- Article
Bone marrow fibrosis at diagnosis is associated with TP53 overexpression and adverse prognosis in low-risk myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2018, v. 181, n. 4, p. 547, doi. 10.1111/bjh.14656
- By:
- Publication type:
- Article